TD Cowen downgraded Leidos from Buy to Hold and set a new price target of $165.00 from $200.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/21/2025 | Outperform → Mkt Perform | William Blair | |
| 2/7/2025 | $185.00 | Overweight | Cantor Fitzgerald |
| 1/8/2025 | $200.00 → $165.00 | Buy → Hold | TD Cowen |
| 12/12/2024 | $228.00 → $153.00 | Buy → Neutral | Goldman |
| 12/2/2024 | $182.00 | Neutral | UBS |
| 1/5/2024 | Equal Weight → Overweight | Barclays | |
| 11/17/2023 | Hold → Buy | Argus | |
| 5/25/2023 | $87.00 → $102.00 | Equal Weight → Overweight | Wells Fargo |
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
SC 13G/A - Leidos Holdings, Inc. (0001336920) (Subject)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
New collaboration delivers robust AI security capabilities to safeguard mission-critical government applications from adversarial threats and vulnerabilities Protect AI, the leading provider of enterprise AI security solutions, is collaborating with Leidos (NYSE:LDOS), a leader in secure digital modernization and mission-critical technology innovation, to strengthen security for AI systems used by U.S. government agencies. The collaboration combines Leidos' expertise in secure digital transformation with Protect AI's platform to enhance end-to-end protection against AI threats—including those posed by next-generation agentic AI models. An agentic model is a type of AI system that is give
RESTON, Va., April 18, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE). The initial focus of the five-year collaboration will be developing AI-powered tools for quicker detection of diseases, such as heart disease and cancer, reducing diagnostic turnaround times, and enabling earlier, more effective care management. "Our investment is aimed at using the transforma
RESTON, Va., April 9, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS), a leading information technology partner for governments worldwide, and Moveworks, the leading agentic artificial intelligence (AI) assistant for enterprises, are collaborating to increase the efficiency of government workers in the U.S., U.K., and Australia. Agentic AI helps people do their work better and faster as a digital personal assistant that knows how to make decisions and automate daily work processes. As commercial organizations are embracing it, the Leidos-Moveworks partnership will allow government age
DEFA14A - Leidos Holdings, Inc. (0001336920) (Filer)
DEF 14A - Leidos Holdings, Inc. (0001336920) (Filer)
PRE 14A - Leidos Holdings, Inc. (0001336920) (Filer)
William Blair downgraded Leidos from Outperform to Mkt Perform
Cantor Fitzgerald initiated coverage of Leidos with a rating of Overweight and set a new price target of $185.00
TD Cowen downgraded Leidos from Buy to Hold and set a new price target of $165.00 from $200.00 previously
LONDON, March 26, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) has selected Adam Clarke as chief executive of Leidos U.K. & Europe effective from 31 March 2025. Clarke brings more than 20 years of experience across aerospace, defence and security sectors to lead Leidos' European operations. He replaces Eric Freeman who is facilitating the transition before returning to the U.S. "Adam's focus on programme excellence and strategic growth aligns perfectly with our vision for our U.K. team," said Vicki Schmanske, Leidos Commercial & International Sector president. "I am confident Adam
Powerhouse Appointees to Drive Innovation and Strengthen Hampton's 10-Year Strategic Plan HAMPTON, Va., March 17, 2025 /PRNewswire/ -- Hampton University is ushering in a bold new era of leadership with the appointment of four distinguished executives to its Board of Trustees: Pleasant Brodnax III '83– Accomplished trial attorney and Hampton alumnusGerard "Gerry" Fasano – Executive Vice President and Chief Growth Officer, LeidosRashida Jones '02, '24– Former president of MSNBC and Hampton alumnaDavid B. Stith '80– Wall Street executive and banking industry leader and Hampton
RESTON, Va., Feb. 25, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) and SeeTrue, an artificial intelligence (AI) software company, are partnering to improve the efficiency of airport security and customs screenings through AI-enabled algorithms for detecting prohibited items. "SeeTrue is an industry leader in threat detection algorithms, and we are excited to join forces with them," said Michael Van Gelder, Senior Vice President, Security Enterprise Solutions (SES) at Leidos. "Through this smart collaboration, we are further demonstrating our commitment to delivering innovative solu
RESTON, Va., April 9, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) today announced it has scheduled a conference call for Tuesday, May 6, 2025, at 8 a.m. (ET) to announce its first quarter 2025 financial results for the period ending April 4, 2025. The company plans to issue its quarterly earnings press release before the conference call on May 6, 2025. The details for the earnings conference call follow: Date: May 6, 2025 Time: 8 a.m. (ET) The company offers a live and replay audio broadcast of the conference call with corresponding press release, presen
RESTON, Va., Feb. 21, 2025 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) ("Holdings") today announced that the previously announced offer by its wholly-owned subsidiary, Leidos, Inc. ("Leidos") to purchase for cash (the "Tender Offer") any and all of its outstanding 3.625% Senior Notes due 2025 (the "2025 Notes") expired at 5:00 p.m., New York City time, on February 20, 2025 (the "Expiration Time"). As of the Expiration Time, $267,393,000 or 53.48% of the $500 million aggregate principal amount outstanding of the 2025 Notes had been validly tendered and not validly withdrawn (not including any amount of 2025 Notes submitted pursuant to the guaranteed delivery procedures described in the
RESTON, Va., Feb. 20, 2025 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) ("Holdings"), today announced the pricing terms of the previously announced offer by its wholly-owned subsidiary, Leidos, Inc. ("Leidos") to purchase for cash (the "Tender Offer") any and all of its outstanding 3.625% Senior Notes due 2025 (the "2025 Notes"). The Tender Offer is being made pursuant to the terms and subject to the conditions set forth in the Offer to Purchase, dated as of February 13, 2025 (the "Offer to Purchase") and the related notice of guaranteed delivery (together with the Offer to Purchase, the "Offer Documents"). Holders of the 2025 Notes ("Holders") are urged to read the Offer Documents care
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)
4 - Leidos Holdings, Inc. (0001336920) (Issuer)